[{"from": "human", "value": "Could you provide a description of this molecule? [C][C][C][C][C][C][O][C][=Branch1][C][=O][/N][=C][Branch2][Branch1][#Branch1][\\C][=C][C][=C][Branch1][Branch1][C][=C][Ring1][=Branch1][N][C][C][=N][C][=C][Branch1][Branch1][N][Ring1][Branch1][C][C][=C][C][=Branch1][Ring2][=C][Ring1][Branch2][C][=Branch1][C][=O][N][Branch1][#Branch2][C][C][C][=Branch1][C][=O][O][C][C][C][=C][C][=C][C][=N][Ring1][=Branch1][/N]"}, {"from": "gpt", "value": "The molecule is an aromatic amide obtained by formal condensation of the carboxy group of 2-{[(4-{N'-[(hexyloxy)carbonyl]carbamimidoyl}phenyl)amino]methyl}-1-methyl-1H-benzimidazole-5-carboxylic acid with the secondary amino group of ethyl N-pyridin-2-yl-beta-alaninate. A prodrug for dabigatran, a thrombin inhibitor and anticoagulant which is used for the prevention of stroke and systemic embolism. It has a role as an anticoagulant, a prodrug and an EC 3.4.21.5 (thrombin) inhibitor. It is a member of benzimidazoles, an aromatic amide, a carboxylic ester, a carboxamidine, a member of pyridines and a beta-alanine derivative. It is functionally related to a dabigatran. It is a conjugate base of a dabigatran etexilate(1+)."}]